What Cent does

Cent (legally CentAI Technologies Private Limited) is a Bengaluru-based preventive healthtech startup that delivers AI-driven full-body early disease detection to health-conscious Indian consumers and corporate wellness buyers. Its core offering is the proprietary CCNM protocol, which combines radiation-free full-body MRI, ultra-low-dose CT calcium scoring, DEXA body composition imaging, ECG, and 100+ blood and urine biomarkers — with an optional Genetics add-on using next-generation sequencing and polygenic risk scoring — to screen for 300+ conditions across cancer, cardiac, neurological, and metabolic disease categories. AI models synthesise the multi-modal imaging, biomarker, and genetic data into the proprietary Tru10 organ-wise health score and a reported 83% Early Detection Index, with all outputs reviewed by certified radiologists and medical specialists before delivery alongside a one-on-one doctor consultation.

The company operates a hybrid distribution model: a flagship 7,000 sq. ft. owned clinical prevention centre in Bengaluru, supported by NABL- and ISO-accredited partner laboratories, imaging centres, and at-home phlebotomy, with active operations in six Indian cities (Bengaluru, Mumbai, Delhi, Chennai, Hyderabad, Pune) and a stated plan to reach 15 cities. Cent monetises through one-time individual scan packages (with a non-refundable ₹5,000 booking reservation and module-based pricing) and an emerging corporate wellness channel offering employee screening programs to enterprises. The company is backed by a $5 million seed round from OneFlow Holdings and South Park Commons (March 2026), is led by founder Shashank ND (Practo co-founder) alongside co-founders Arpit Garg (Chief AI and Research Officer) and Anshul Khandelwal (Chief Business Officer), and has set a long-term strategic target of 10 million scans and 1 million lives saved by 2035.

Name

Cent

Legal name

CentAI Technologies Private Limited

Website

https://cent.health

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

51–100 employees

Short description

Cent is a Bengaluru-based preventive healthtech startup that uses its proprietary CCNM AI protocol combining full-body MRI, CT, DEXA, 100+ biomarkers and optional genetics to screen Indian consumers and corporate employees for 300+ conditions across cancer, cardiac, neuro and metabolic diseases.

Ownership category

akta.pro rank

Product category

Preventive Health Screening

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Population Genomics & Preventive Precision Health Programs (HLAAANAL)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Preventive health screening
• Full-body MRI scans
• Early disease detection
• Corporate wellness programs
• AI health diagnostics

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Individual Health Scans: Direct-to-consumer revenue from comprehensive health checkup packages combining MRI, CT calcium scoring, DEXA, biomarkers, and optional genetics. Services delivered at owned centers or partner facilities with booking fees of ₹5,000 and full scan packages priced based on selected modules.
2. Corporate Wellness Programs: B2B revenue stream offering employee preventive health checkups as corporate benefits. Targets enterprises looking to improve employee well-being, retention, and reduce healthcare costs through comprehensive screening programs.
3. Doctor Consultation Services: One-on-one specialist consultations included with scan packages where doctors review results and provide personalized recommendations, creating follow-on service opportunities.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Cent provides comprehensive preventive health screening services through its proprietary CCNM protocol that combines full-body MRI, CT calcium scoring, DEXA scans, ECG, and 100+ blood and urine biomarkers into a single AI-synthesized report. The service targets 300+ health conditions across cancer, cardiac, neurological, and metabolic disease categories, delivered via owned clinical centers in major Indian cities and partner-accredited labs, with optional add-on genetic testing (NGS and PRS).

Product overview

Cent is India's most comprehensive full-body health checkup and MRI-based early disease detection platform. The core offering is the proprietary CCNM Scan protocol that combines advanced imaging (full-body MRI, ultra-low-dose CT Calcium Scoring, DEXA), deep biomarker analysis (100+ blood and urine markers), and AI-driven synthesis into one integrated preventive health assessment. The company offers two product modules: the base CCNM Scan for comprehensive early detection, and the CCNM Scan + Genetics Module which adds DNA-based risk analysis including Next-Generation Sequencing and Polygenic Risk Scoring. Both modules include doctor consultation and generate an organ-wise Tru10 health score report.

Differentiator

Problem solved

Functional benefit

Products and services

• Cent CCNM Scan Comprehensive early detection protocol combining full-body MRI, CT Calcium Scoring, DEXA scan, ECG, and 100+ blood and urine biomarkers to screen for 300+ health conditions across cancer, cardiac, neurological, and metabolic disease categories. Includes AI-synthesized organ-wise Tru10 health score report and doctor consultation, targeted at health-conscious individuals and enterprises seeking preventive screening.
• Cent CCNM Scan + Genetics Module Enhanced version of the core CCNM Scan that adds DNA-based risk analysis using Next-Generation Sequencing (NGS) and Polygenic Risk Scoring (PRS) for inherited predispositions to heart disease, cancer, and metabolic conditions. The genetics component is a one-time test layered on top of the core scan package.

Quantifiable outcome

• 83% Early Detection Index (vs 27% for traditional checkups)
• +5 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

One partnership is on record.

• Siemens HealthineerscoreTechnology or Integration · 1 April 2026Deepened partnership with Siemens Healthineers for advanced imaging capabilities at Cent's owned detection centers. Siemens provides CT and MRI technology infrastructure supporting the company's comprehensive early disease detection platform.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Prenuvo: US-based full-body MRI preventive screening company offering radiation-free whole-body imaging plus optional biomarker add-ons. Operates in the same premium preventive-screening category as Cent and competes for health-conscious consumers seeking early disease detection.
• Fountain Life: Preventive health and longevity company using advanced imaging, blood biomarkers, and AI to detect disease early in asymptomatic individuals. Direct peer to Cent on the owned-center, multi-modal screening model.
• Function Health: US-based preventive health platform offering comprehensive blood biomarker panels plus add-on imaging, with AI-driven insights and doctor consultation. Comparable to Cent's CCNM protocol on the multi-biomarker + AI synthesis model.
• Ezra: New York-based full-body MRI screening startup offering 30–60 minute AI-assisted whole-body scans for early cancer and disease detection. Direct comparable to Cent on product (full-body MRI screening) and consumer proposition.
• Healthians: Indian at-home diagnostic and preventive health testing company offering comprehensive health packages with home sample collection. Comparable to Cent on India-focused DTC preventive diagnostics, though less imaging-heavy.
• Human Longevity Inc. Founder-led precision health company combining whole-genome sequencing, advanced imaging, and AI-driven health intelligence. Comparable to Cent on integrating imaging, genetics, and AI for early disease detection.

Broad incumbents

• Apollo Diagnostics: Diagnostic arm of Apollo Hospitals, India's largest hospital network, offering imaging and lab diagnostics across hundreds of centers. Broad incumbent comparable to Cent's imaging + lab model with established physician referral networks.
• Thyrocare Technologies: One of India's largest diagnostic chains offering low-cost preventive packages at massive scale. Broad incumbent comparable to Cent on Indian preventive diagnostics market, though positioned on price and volume rather than premium full-body imaging.
• Practo: India's largest consumer healthtech platform for doctor booking, telemedicine, and integrated diagnostics — founded by Cent's founder Shashank ND. Broad incumbent relevant as both a precedent playbook and potential competitor/partner in Indian preventive health.
• Tata 1mg: Leading Indian online pharmacy and diagnostics platform offering lab test booking and at-home sample collection. Broad incumbent comparable to Cent on India's DTC diagnostics distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cent